Text on screen:
Revolutionising treatment for people with cancer
Ravi Barod, Consultant urological surgeon and robotic surgery programme lead
Interview:
We’ve had a very successful robotic program that’s been running for ten years now at the Royal Free. And over those ten years, we’ve gone from a hospital that performs very little robotic surgery to one of the highest volume kidney cancer centres in Europe.
Training sequence:
If you could just come here, Mark, bring in your sucker, and then you’re going to put the tip of it there, and you’re going to take the sucker down to eight o’clock, like that. Beautiful. And that’s enough. No more than that. There we go. That looks nice there doesn’t it? Yeah.
Ravi Barod, Consultant urological surgeon and robotic surgery programme lead
Interview:
About 92% of the operations that we now perform are performed using the surgical robot. Patients lose less blood during their operation. They’re in less pain after their operation, and they get back to their normal lives a lot quicker. It’s a real game changer for a lot of complex surgery.
The incision is just the width of your little finger, about eight millimetres in size. We put a camera in one incision and we put instruments in the other three, and whatever movements that are made in my hand get copied by the instruments that will be docked in the robot. But the robotic instruments, they have 720 degrees of movement, which really means that there’s some things that we can do that we just couldn’t do with open surgery.
Training sequence:
Thank you. Keep going, keep going. Very good.
Ravi Barod, Consultant urological surgeon and robotic surgery programme lead
Interview:
One of the patients who really experienced the benefit from robotic surgery was one of the first patients that we offered removal of the kidney or nephrectomy to as a day case.
This was a young patient who had a tumour in their kidney. And we were able to offer him an operation where he came in at eight o’clock in the morning, had his surgery, he was recovered and was discharged by seven pm that evening. And this has really revolutionised the concepts associated with major cancer surgery. And this is something that every patient would wantand what we would want to give to all of our patients.
At the Royal Free Hospital, we are a complex surgical hub, and we accept patients from all over the country, and that demand is only increasing.
We use this robot probably about six days a week, and another speciality will use it another day of the week, but there just is not enough capacity anymore for us to expand this technology to other specialities because clearly they need time and training on the robot in order to start their programs.
Professor Joerg-Matthias Pollok, Consultant hepato-pancreato-biliary (HBP) surgeon
Interview:
In the moment, we don’t have access to the robot for complex HPB (liver, pancreas, gall bladder, bile ducts) surgery. But, we would see that this could have huge impact on the patients in our service.
Angeline Shoniwa, Operating theatres senior nurse
Interview:
The training that is involved in it is exciting. And it’s an incentive as well, for us to keep staff because there is the future of surgery. So everyone will want to come and work with us.
Ravi Barod, Consultant urological surgeon and robotic surgery programme lead
Interview:
With the new robot, they will be able to develop minimally invasive ways of doing those operations, which, means that their recovery will be quicker. And if they are in and out of hospital quicker, then more patients can be operated on.
Professor Joerg-Matthias Pollok, Consultant hepato-pancreato-biliary (HBP) surgeon
Interview:
We have the chance to not only develop HPB cancer surgery with the robot in our local hospital, but beyond, develop this for the nation and for the world to provide better service for patients in the future.
Angeline Shoniwa, Operating theatres senior nurse
Interview:
So if you are thinking of donating, we’ll be really grateful. Thank you very much.
Text on screen:
The future of robotic surgery is here.
Your support is vital to enable us to purchase this cutting-edge technology for cancer patients at the Royal Free.
Contact Russell Delew, Director of Fundraising and Campaigns: [email protected].
Charity number: 1165672.